AIM ImmunoTech Inc (AMEX:AIM) has a beta value of 0.36 and has seen 1.14 million shares traded in the last trading session. The company, currently valued at $9.42M, closed the last trade at $0.14 per share which meant it gained $0.01 on the day or 6.20% during that session. The AIM stock price is -342.86% off its 52-week high price of $0.62 and 14.29% above the 52-week low of $0.12.
The consensus among analysts is that AIM ImmunoTech Inc (AIM) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.09.
AIM ImmunoTech Inc (AMEX:AIM) trade information
Sporting 6.20% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the AIM stock price touched $0.14 or saw a rise of 12.5%. Year-to-date, AIM ImmunoTech Inc shares have moved -30.81%, while the 5-day performance has seen it change -3.59%. Over the past 30 days, the shares of AIM ImmunoTech Inc (AMEX:AIM) have changed -30.53%.
AIM ImmunoTech Inc (AIM) estimates and forecasts
The company’s shares have lost -52.74% over the past 6 months. Revenue growth from the last financial year stood is estimated to be -0.99%.
1 analysts offering their estimates for the company have set an average revenue estimate of 100k for the current quarter. Year-ago sales stood 65k and 40k respectively for this quarter and the next, and analysts expect sales will grow by 53.85% for the current quarter and -0.99% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 42.86% over the past 5 years.
AIM Dividends
AIM ImmunoTech Inc is expected to release its next earnings report in March this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
AIM ImmunoTech Inc (AMEX:AIM)’s Major holders
The top two institutional holders are ARMISTICE CAPITAL, LLC with over 4.08 million shares worth more than $1.52 million. As of 2024-06-30, ARMISTICE CAPITAL, LLC held 7.718% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 1.99 million shares as of 2024-06-30. The firm’s total holdings are worth over $0.74 million and represent 4.021% of shares outstanding.
